t seems like ages since President Trump castigated drug company executives for “getting away with murder” and promised to take on the powerful pharma lobby.

While the spotlight has shifted (and the threat of a crackdown has dimmed), the pharma industry still has plenty on its plate. The man charged with pushing the industry’s agenda is Stephen J. Ubl, the president and CEO of the PhRMA trade group. He stopped by the STAT offices in Boston this week to talk about his plans — and the challenges he’s confronting. Here are the highlights:

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • You give front page space to Big Pharma’s highest paid Liar? And you have some rookie do the “interview?” Did Ed Silverman throw up? This is not journalism, this is pandering to advertisers. Shame on WHOEVER thought this was a good idea!

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.